2-(4-Iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium Sodium Salt - CAS 515111-36-1
Catalog: |
BB027465 |
Product Name: |
2-(4-Iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium Sodium Salt |
CAS: |
515111-36-1 |
Synonyms: |
sodium;4-[2-(2,4-dinitrophenyl)-3-(4-iodophenyl)-5-tetrazol-2-iumyl]benzene-1,3-disulfonate; sodium;4-[2-(2,4-dinitrophenyl)-3-(4-iodophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate |
IUPAC Name: | sodium;4-[2-(2,4-dinitrophenyl)-3-(4-iodophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate |
Description: | A highly sensitive tetrazolium reagent (light red) that produces a water-soluble formazan (dark red color). Water-soluble tetrazolium salts (WSTs) were developed by introducing positive or negative charges and hydroxy groups to the phenyl ring of the tetrazolium salt.WST-3 formazan l max = 433nm; e= 3.1 x 104. |
Molecular Weight: | 696.34 |
Molecular Formula: | C19H10IN6O10S2Na |
Canonical SMILES: | C1=CC(=CC=C1N2N=C(N=[N+]2C3=C(C=C(C=C3)[N+](=O)[O-])[N+](=O)[O-])C4=C(C=C(C=C4)S(=O)(=O)[O-])S(=O)(=O)[O-])I.[Na+] |
InChI: | InChI=1S/C19H11IN6O10S2.Na/c20-11-1-3-12(4-2-11)23-21-19(15-7-6-14(37(31,32)33)10-18(15)38(34,35)36)22-24(23)16-8-5-13(25(27)28)9-17(16)26(29)30;/h1-10H,(H-,31,32,33,34,35,36);/q;+1/p-1 |
InChI Key: | LKVNWZJLLRMMAS-UHFFFAOYSA-M |
LogP: | 4.64820 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2021062240-A1 | Systems and methods for performing antimicrobial susceptibility testing | 20190827 |
US-2020325518-A1 | Systems and Methods for Metabolic Assessment Utilizing 1-Methoxy-PMS Field | 20190327 |
WO-2020198638-A1 | Systems and methods for metabolic assessment utilizing 1-methoxy-pms | 20190327 |
US-2019323057-A1 | System, method and interface for parallel processing of antimicrobial susceptibility tests using different samples | 20180327 |
WO-2019191328-A1 | System, method and interface for parallel processing of antimicrobial susceptibility tests using different samples | 20180327 |
Complexity: | 1070 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 695.88422 |
Formal Charge: | 0 |
Heavy Atom Count: | 39 |
Hydrogen Bond Acceptor Count: | 12 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 695.88422 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 257 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS